Today’s top gainers include the company Quest Diagnostics Inc. (NYSE:DGX) which is in the industry Medical Laboratories & Research, gaining 1.02% today. In the last week its performance is 0.55%, and 12.38% for the past quarter. Currently, Quest Diagnostics Inc., DGX has a target price of 75.8, so today’s gain of 1.02% is a significant step towards its target price. The GAP today is therefore 0.00%.
Quest Diagnostics Inc. (NYSE:DGX), has a market cap of 11857.16, and is based in USA. Insider ownership is at 0.40%, and institutional ownership is 96.50%.
At the current price of 84.41, it has a dividend yield of 1.91%, and its target price is 75.8. This is with a profit margin of 9.90%, and total debt/equity of 0.84. Quest Diagnostics Inc. (NYSE:DGX) has a P/E of 16.19, as well as a forward P/E of 15.39.
With a current EPS of 5.16, and a forecasted EPS growth for next year at 6.56%,Quest Diagnostics Inc. (NYSE:DGX) has had a EPS growth for the past five years at 4.10%. For the next five years EPS growth is projected to be 7.72%.
Performance for the year is 18.52%. Since its IPO date on 12/26/1996, the total performance to date is 19.36%.
Volume today for Quest Diagnostics Inc. (NYSE:DGX), is 894975, while its average volume is 1186.96. Whilst the total gain today was 1.02%, it did have a day high of 0.52%.
Volatility for this week has been at 1.05%, and 1.33% for the month. The 52-week low for Quest Diagnostics Inc., DGX has been 43.68%, while the 52-week-high has reached 0.52%.
Looking at its return of investments, which is 12.30%, and its return on assets is 7.50%. Quest Diagnostics Inc. (NYSE:DGX) has an operating margin of 19.00%. With a sales growth of 1.30% quarter over quarter. Bearing in mind that Quest Diagnostics Inc., DGX is in the sector Healthcare, its long-term debt/equity is 0.81, and has a current ratio of 1.4 and 1.3 for quick ratio.
So what is the value of Quest Diagnostics Inc.? Well its PEG is 2.1, and the P/S is 1.58, along with a P/B of 2.58. Meanwhile it has a p/cash of 92.63.